Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 05, 2020

SELL
$220.06 - $304.07 $231,063 - $319,273
-1,050 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$278.5 - $352.75 $126,717 - $160,501
-455 Reduced 30.23%
1,050 $316,000
Q3 2017

Oct 24, 2017

BUY
$281.15 - $329.69 $423,130 - $496,183
1,505
1,505 $471,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $26.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Redw Wealth LLC Portfolio

Follow Redw Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redw Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redw Wealth LLC with notifications on news.